EUVIMEDEUVIMED entdecken
Crossref

A pregnancy‐specific Glucose management indicator derived from continuous glucose monitoring in pregnant women with type 1 diabetes

Ping Ling iD, Daizhi Yang iD, Chaofan Wang, Xueying Zheng iD, Sihui Luo iD, Xubin Yang iD, Hongrong Deng, Wen Xu iD, Jinhua Yan iD, Jianping Weng iD

Diabetes/Metabolism Research and Reviews · 2023

DOI: 10.1002/dmrr.3689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes/Metabolism Research and Reviews, 2023. Verfasst von Ping Ling und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diabetolo…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Blood Glucose Self-Monitoring, Blood Glucose, Pregnancy in Diabetics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Diabetes mellitus research fund program from Shanghai Medical and Health development foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Glucose management indicator (GMI) is a core metric derived from continuous glucose monitoring (CGM) and is widely used to evaluate glucose control in patients with diabetes. No study has explored the pregnancy‐specific GMI. This study aimed to derive a best‐fitting model to calculate GMI from mean blood glucose (MBG) obtained from CGM among pregnant women with type 1 diabetes mellitus (T1DM).

Methods

A total of 272 CGM data and corresponding laboratory HbA1c from 98 pregnant women with T1DM in the CARNATION study were analysed in this study. Continuous glucose monitoring data were collected to calculate MBG, time‐in‐range (TIR), and glycaemic variability parameters. The relationships between the MBG and HbA1c during pregnancy and postpartum were explored. Mix‐effect regression analysis with polynomial terms and cross‐validation method was conducted to investigate the best‐fitting model to calculate GMI from MBG obtained by CGM.

Results

The pregnant women had a mean age of 28.9 ± 3.8 years, with a diabetes duration of 8.8 ± 6.2 years and a mean body mass index (BMI) of 21.1 ± 2.5 kg/m 2 . The HbA1c levels were 6.1 ± 1.0% and 6.4 ± 1.0% during pregnancy and at postpartum ( p = 0.024). The MBG levels were lower during pregnancy than those at postpartum (6.5 ± 1.1 mmol/L vs. 7.1 ± 1.5 mmol/L, p = 0.008). After adjusting the confounders of haemoglobin (Hb), BMI, trimesters, disease duration, mean amplitude of glycaemic excursions and CV%, we developed a pregnancy‐specific GMI‐MBG equation: GMI for pregnancy (%) = 0.84–0.28* [Trimester] + 0.08 * [ BMI in kg/m 2 ] + 0.01 * [Hb in g/mL] + 0.50 * [MBG in mmol/L].

Conclusions

We derived a pregnancy‐specific GMI equation, which should be recommended for antenatal clinical care. Clinical trial registry number ChiCTR1900025955.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Blood Glucose Self-MonitoringBlood GlucosePregnancy in DiabeticsGlycemic ControlBiomarkersHumansFemalePregnancyAdultGlycated HemoglobinFollow-Up StudiesPrognosisHypoglycemic AgentsContinuous Glucose Monitoring

Stichwörter der Autor:innen

diabetes mellitusglucose management indicatorglycated haemoglobin A1cpregnancytype 1

Substanzen

Blood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanBiomarkersHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diabetology, Sun Yat-Sen University, Guangzhou, China.
  • Department of Endocrinology, Institute of Endocrine and Metabolic Disease, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Clinical Research Hospital of Chinese Academy of Sciences (Hefei)…

ORCID-Profile: Ping Ling, Daizhi Yang, Xueying Zheng, Sihui Luo, Xubin Yang, Wen Xu, Jinhua Yan, Jianping Weng

Förderung

  • National Key Research and Development Program of China
  • Diabetes mellitus research fund program from Shanghai Medical and Health development foundation
  • National Natural Science Foundation of China
  • Science and Technology Planning Project of Guangzhou

Zitieren

APA

Ling, P., Yang, D., Wang, C., Zheng, X., Luo, S., Yang, X., Deng, H., Xu, W., Yan, J., & Weng, J. (2023). A pregnancy‐specific Glucose management indicator derived from continuous glucose monitoring in pregnant women with type 1 diabetes. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.3689

Vancouver

Ling P, Yang D, Wang C, Zheng X, Luo S, Yang X, et al. A pregnancy‐specific Glucose management indicator derived from continuous glucose monitoring in pregnant women with type 1 diabetes. Diabetes/Metabolism Research and Reviews. 2023. doi:10.1002/dmrr.3689

BibTeX
@article{Ling2023,
  author = {Ling, Ping and Yang, Daizhi and Wang, Chaofan and Zheng, Xueying and Luo, Sihui and Yang, Xubin and Deng, Hongrong and Xu, Wen and Yan, Jinhua and Weng, Jianping},
  title = {A pregnancy‐specific Glucose management indicator derived from continuous glucose monitoring in pregnant women with type 1 diabetes},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2023},
  doi = {10.1002/dmrr.3689}
}
Kostenlos starten →